655
Participants
Start Date
November 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Alogliptin
Alogliptin tablets.
Pioglitazone
Pioglitazone tablets.
Placebo
Matching placebo tablets.
Columbiana
Hueytown
Huntsville
Northport
Tucson
Jonesboro
Little Rock
Searcy
Foothill Ranch
Irvine
Northridge
San Diego
San Mateo
Santa Monica
Jacksonville
Melbourne
Miami
Port Charlotte
Sebastian
South Miami
Winter Haven
Augusta
Barnesville
Columbus
Savannah
Chicago
Libertyville
South Bend
Bossier City
Elkton
Prince Frederick
Towson
North Dartmouth
Bay City
Benzonia
Portage
Saint Clair Shores
Picayune
St Louis
Billings
Las Vegas
Elizabeth
Hamilton
Cicero
Charlotte
Mooresville
Northeast
Franklin
Ashland
Altoona
Fleetwood
Harleysville
Havertown
Norristown
Northern Cambria
Penndel
Philadelphia
Charleston
Florence
Orangeburg
Taylors
Williamston
Morristown
Arlington
Colleyville
Conroe
Corpus Christi
Dallas
Euless
Fort Worth
Garland
Houston
Katy
San Antonio
Seguin
Sugarland
Tomball
Ogden
Arlington
Norfolk
Richmond
Lewisburg
Milwaukee
Cap. Fed.
Chacabuco
La Plata
Mar del Plata
Morón
Córdoba
Kingswood
Fitzroy
Frankston
Fortaleza
Goiás
Curitiba
Belém
Maringá
Marília
Mogi das Cruzes
Pleven
Santiago
Slavonski Brod
Pärnu
Guatemala City
Budapest
Eger
Gyula
Makó
Nyíregyháza
Pécs
Hyderabad
Bangalore
Aurangabad
Mumbai
Nagpur
Chennai
Hadera
Haifa
Holon
Jaffa Tel Aviv
Jerusalem
Nahariya
Riga
Kaunas
Kėdainiai
Aguascalientes
Mexico City
Monterrey
Christchurch
Hamilton
Bialystok
Bytom
Gdansk
Gniewkowo
Kamieniec Ząbkowicki
Krakow
Łęczyca
Brasov
Bucharest
Galati
Kazan'
Moscow
Yekaterinburg
Belgrade
Kragujevac
Niš
Interna Klinika II
Banska Bysterica
Lučenec
Riverside
Šahy
Port Elizabeth
Johannesburg
Durban
East Lynne
Bellville
Cape Town
Dnipropetrovsk
Kharkiv
Lviv
Odesa
Lead Sponsor
Takeda
INDUSTRY